DOXIPHAR 25%

For the treatment of Mycoplasma hyopneumoniae, Pasteurella spp, Actinobacillus pleuropneumoniae, Glaeserella parasuis, Streptococcus suis, Bordetella bronchiseptica, Salmonella sp, E. coli, Clostridium spp, Treatment of ileitis (Lawsonia intracellularis), Leptospirosis Abcesses and arthritis (Streptococcus and Mycoplasma spp.), Erysipelas (Erisipelothrix rhusiopathiae), agents that can cause pneumonia, bronchopneumonia, atrophic rhinitis, diarrhea and arthritis.